Outreach and Connection to Care for Chronic Kidney Disease in a Workplace Wellness Setting: A Cost-Effectiveness Analysis

被引:0
|
作者
Li, Yonghong [1 ]
Devlin, James J. [1 ]
机构
[1] Quest Diagnost, 33608 Ortega Highway, San Juan Capistrano, CA 92675 USA
关键词
chronic kidney disease; cost-effectiveness analysis; Markov modeling; CARDIOVASCULAR OUTCOMES; NEPHROPATHY; INHIBITORS;
D O I
10.1089/pop.2019.0206
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Because chronic kidney disease (CKD) is underdiagnosed, many patients do not receive care that could slow or prevent progression. Potential CKD patients can be identified during employee wellness events and referred into care by a CKD outreach program. This study assessed the health and economic benefits associated with a CKD outreach program. A model-based cost-effectiveness analysis was conducted for a cohort of patients at risk for CKD under 2 scenarios: wellness events with a CKD outreach program and wellness events without outreach. The outreach program identified potential CKD patients based on estimated glomerular filtration rates. Health outcomes and total cost to payers were estimated with Markov models using 1-year cycles. Because outreach could be offered to either patients with diabetes or to all potential CKD patients, these groups were modeled separately. The authors assumed 40% percent of potential CKD patients accepted the invitation to participate in the CKD outreach program. Model parameters were taken from peer-reviewed literature. The study was conducted from the perspective of self-insured employers over a 5-year time horizon. The study found that the CKD outreach program resulted in a gain of 2.3 quality-adjusted life-years and saved $500,211 when 1000 potential CKD patients with diabetes were invited. When potential CKD patients were invited without regard for diabetes status, 0.8 quality-adjusted life-years were gained at a cost savings of $34,161. The authors concluded that CKD outreach programs can improve health outcomes for patients with CKD and save costs for payers.
引用
下载
收藏
页码:487 / 494
页数:8
相关论文
共 50 条
  • [31] Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
    Ramos, Mafalda
    Gerlier, Laetitia
    Uster, Anastasia
    Muttram, Louise
    Frankel, Andrew H.
    Lamotte, Mark
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 777 - 785
  • [32] Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
    Lin, Eugene
    Chertow, Glenn M.
    Yan, Brandon
    Malcolm, Elizabeth
    Goldhaber-Fiebert, Jeremy D.
    PLOS MEDICINE, 2018, 15 (03)
  • [33] COST-EFFECTIVENESS ANALYSIS OF USING KETOANALOGUES OF ESSENTIAL AMINOACIDS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN KAZAKHSTAN
    Avdeyev, A.
    Gulyaev, A.
    Akhmedullin, R.
    VALUE IN HEALTH, 2023, 26 (12) : S73 - S73
  • [34] Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
    Howard, Kirsten
    White, Sarah
    Salkeld, Glenn
    McDonald, Stephen
    Craig, Jonathan C.
    Chadban, Steven
    Cass, Alan
    VALUE IN HEALTH, 2010, 13 (02) : 196 - 208
  • [35] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF HEALTH-CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1988, 18 (01): : 1 - 9
  • [36] Priority Setting, Cost-Effectiveness, and the Affordable Care Act
    Persad, Govind
    AMERICAN JOURNAL OF LAW & MEDICINE, 2015, 41 (01) : 119 - 166
  • [37] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Benjamin O. Yarnoff
    Thomas J. Hoerger
    Siobhan K. Simpson
    Alyssa Leib
    Nilka R. Burrows
    Sundar S. Shrestha
    Meda E. Pavkov
    BMC Nephrology, 18
  • [38] Needs and cost-effectiveness in health care priority setting
    Gustavsson, Erik
    Tinghog, Gustav
    HEALTH AND TECHNOLOGY, 2020, 10 (03) : 611 - 619
  • [39] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Yarnoff, Benjamin O.
    Hoerger, Thomas J.
    Simpson, Siobhan K.
    Leib, Alyssa
    Burrows, Nilka R.
    Shrestha, Sundar S.
    Pavkov, Meda E.
    BMC NEPHROLOGY, 2017, 18
  • [40] Needs and cost-effectiveness in health care priority setting
    Erik Gustavsson
    Gustav Tinghög
    Health and Technology, 2020, 10 : 611 - 619